Literature DB >> 9558424

Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.

T L Stendal1, W Klem, H H Tønnesen, I Kjønniksen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9558424     DOI： 10.1093/ajhp/55.7.683

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?

Authors:  P Bourget; A Amin; C Dupont; M Abely; N Desmazes-Dufeu; J C Dubus; B-L Jouani; C Merlette; R Nové-Josserand; J Pages; R Panzo; F Vidal; F Voge; D Hubert
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

2.  Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.

Authors:  H Servais; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

3.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 4.  Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review.

Authors:  Beatriz Fernández-Rubio; Paula Del Valle-Moreno; Laura Herrera-Hidalgo; Alicia Gutiérrez-Valencia; Rafael Luque-Márquez; Luis E López-Cortés; José María Gutiérrez-Urbón; Sonia Luque-Pardos; Aurora Fernández-Polo; María V Gil-Navarro
Journal:  Antibiotics (Basel)       Date:  2021-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.